Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.18 trillion and total revenue of $110.17 billion.
Market Cap
1.18T
Revenue
110.17B
Profits
-39.88B
PE Ratio
n/a
Profit Margin
-36.20%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.89B | 0.50% | 231,027 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.32B | 2.22% | 334,411 | 14.34B |
| 3 | ARGX | argenx SE | 49.44B | 0.73% | 114,050 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.55B | 0.88% | 220,740 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.54B | -3.19% | 168,163 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.89B | -0.96% | 361,424 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 29.40B | -0.26% | 976,132 | 2.38B |
| 8 | RVMD | Revolution Medicines, Inc. | 28.73B | -3.46% | 1,787,862 | - |
| 9 | BNTX | BioNTech SE | 27.00B | -1.68% | 234,430 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.53B | -2.36% | 1,398,262 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.58B | -1.37% | 1,543,838 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.18B | -0.36% | 245,362 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 17.99B | -5.70% | 2,377,328 | - |
| 14 | GMAB | Genmab A/S | 17.10B | -1.99% | 395,276 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.20B | -1.61% | 1,155,905 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.10B | -1.22% | 354,712 | 845.52M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.39B | -0.54% | 225,599 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.33B | -0.23% | 352,449 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.97B | -1.39% | 72,349 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.85B | -0.43% | 712,914 | 2.32B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.65B | 2.85% | 1,022,647 | 1.09B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.36B | -0.52% | 383,738 | 3.22B |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 9.48B | 0.95% | 121,941 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.45B | -0.91% | 174,973 | 638.50M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.20B | -1.87% | 299,918 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.61B | -1.58% | 256,079 | - |
| 27 | NUVL | Nuvalent, Inc. | 8.48B | -0.93% | 304,407 | - |
| 28 | IBRX | ImmunityBio, Inc. | 8.29B | -0.50% | 4,446,268 | 113.29M |
| 29 | TECH | Bio-Techne Corporation | 8.20B | -10.52% | 1,391,465 | 1.22B |
| 30 | CYTK | Cytokinetics, Incorporated | 8.13B | -1.24% | 650,409 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 8.06B | -0.76% | 64,547 | 389.13M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 8.05B | -0.64% | 865,692 | 1.40B |
| 33 | ERAS | Erasca, Inc. | 7.19B | 6.88% | 4,537,469 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 7.16B | -1.14% | 114,748 | 39.21M |
| 35 | ACLX | Arcellx, Inc. | 6.75B | 0.07% | 669,368 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.66B | -1.07% | 107,132 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.61B | -1.30% | 103,681 | - |
| 38 | BLTE | Belite Bio, Inc | 6.57B | -0.27% | 14,168 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.01% | 1,359,134 | 15.00M |
| 40 | SYRE | Spyre Therapeutics, Inc. | 6.10B | -3.12% | 198,901 | - |
| 41 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.03% | 1,118,075 | - |
| 42 | IMVT | Immunovant, Inc. | 6.00B | - | 574,515 | - |
| 43 | CGON | CG Oncology, Inc. | 5.90B | 0.04% | 492,023 | 4.04M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.87B | 0.98% | 137,602 | 189.76M |
| 45 | PTCT | PTC Therapeutics, Inc. | 5.80B | -1.19% | 236,441 | 1.73B |
| 46 | COGT | Cogent Biosciences, Inc. | 5.77B | -1.48% | 253,477 | - |
| 47 | CELC | Celcuity Inc. | 5.62B | -5.09% | 201,871 | - |
| 48 | TGTX | TG Therapeutics, Inc. | 5.61B | -0.91% | 564,504 | 616.29M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.58B | -3.71% | 669,744 | 812.03M |
| 50 | MIRM | Mirum Pharmaceuticals, Inc. | 5.58B | -2.03% | 115,024 | 521.31M |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.55B | 2.01% | 353,762 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.48B | 0.85% | 537,653 | 3.51M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.35B | -1.04% | 168,116 | 7.50M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | 0.01% | 1,325,553 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.02B | 0.94% | 94,021 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.85B | -3.05% | 402,586 | 761.41M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.03% | 949,961 | 634.21M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.53B | 0.05% | 31,500 | 268.09M |
| 59 | LEGN | Legend Biotech Corporation | 4.41B | -8.06% | 1,103,311 | 1.03B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.06B | -0.79% | 236,702 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.90B | -1.78% | 621,053 | - |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.79B | 2.24% | 636,998 | 490.73M |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.76B | -3.23% | 968,042 | 62.38M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.76B | -0.94% | 300,487 | 1.07B |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.67B | -0.16% | 207,647 | 22.50M |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.50B | -0.77% | 59,976 | 803.79M |
| 67 | ORKA | Oruka Therapeutics, Inc. | 3.43B | -1.83% | 871,003 | - |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.43B | -0.59% | 285,257 | - |
| 69 | ALMS | Alumis Inc. | 3.38B | 2.78% | 1,006,211 | 24.05M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.35B | 1.76% | 308,040 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.27B | 3.20% | 893,632 | 588.99M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.16B | -2.64% | 681,256 | - |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.16B | -5.45% | 438,341 | 247.00M |
| 74 | DNLI | Denali Therapeutics Inc. | 3.13B | -2.52% | 338,568 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 3.12B | -1.77% | 697,464 | 139.74M |
| 76 | KLRA | Kailera Therapeutics, Inc. | 3.08B | 2.51% | 647,837 | - |
| 77 | NKTR | Nektar Therapeutics | 3.01B | -2.78% | 845,009 | 55.23M |
| 78 | RLAY | Relay Therapeutics, Inc. | 2.96B | -5.33% | 889,791 | 15.36M |
| 79 | KOD | Kodiak Sciences Inc. | 2.85B | 2.10% | 133,106 | - |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 2.81B | -4.59% | 262,499 | 376.07M |
| 81 | VERA | Vera Therapeutics, Inc. | 2.76B | -4.42% | 224,475 | - |
| 82 | IDYA | IDEAYA Biosciences, Inc. | 2.74B | -1.34% | 505,652 | 218.71M |
| 83 | SLNO | Soleno Therapeutics, Inc. | 2.73B | -0.01% | 587,573 | 190.41M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.67B | -0.44% | 217,473 | 1.55M |
| 85 | IMNM | Immunome, Inc. | 2.65B | -1.39% | 169,877 | 6.94M |
| 86 | MANE | Veradermics, Incorporated | 2.65B | 1.00% | 85,202 | - |
| 87 | IRON | Disc Medicine, Inc. | 2.63B | -0.98% | 67,127 | - |
| 88 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -1.33% | 140,215 | - |
| 89 | ADMA | ADMA Biologics, Inc. | 2.60B | 2.37% | 1,741,585 | 510.17M |
| 90 | TARS | Tarsus Pharmaceuticals, Inc. | 2.60B | -3.81% | 231,595 | 451.36M |
| 91 | ZLAB | Zai Lab Limited | 2.46B | -4.37% | 250,838 | 460.16M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42B | 0.14% | 296,498 | 673.00M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | -1.00% | 199,290 | - |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.36B | 2.47% | 1,039,123 | - |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | - | 158.18M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.22B | 0.11% | 250,949 | - |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -0.58% | 510,840 | 283.06M |
| 98 | AAPG | Ascentage Pharma Group International | 2.15B | -8.48% | 4,604 | 82.08M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | -1.74% | 2,991,351 | 2.20B |
| 100 | ADPT | Adaptive Biotechnologies Corporation | 2.12B | -3.03% | 335,093 | 276.98M |
| 101 | STOK | Stoke Therapeutics, Inc. | 2.12B | -0.39% | 88,175 | 184.42M |
| 102 | OCUL | Ocular Therapeutix, Inc. | 2.08B | -1.09% | 483,180 | 51.95M |
| 103 | ZYME | Zymeworks Inc. | 2.08B | -1.37% | 237,140 | 105.97M |
| 104 | MESO | Mesoblast Limited | 2.02B | -1.43% | 39,657 | 65.38M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 2.00B | -3.45% | 902,079 | - |
| 106 | CAPR | Capricor Therapeutics, Inc. | 1.95B | -3.51% | 301,704 | 11.13M |
| 107 | NTLA | Intellia Therapeutics, Inc. | 1.94B | -0.94% | 1,335,781 | 67.67M |
| 108 | GLPG | Galapagos NV | 1.92B | -1.00% | 37,264 | 1.31B |
| 109 | PHVS | Pharvaris N.V. | 1.90B | -3.20% | 76,126 | - |
| 110 | SION | Sionna Therapeutics, Inc. | 1.90B | -2.22% | 74,128 | - |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.90B | -1.56% | 785,742 | 9.77M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.88B | -3.26% | 1,285,468 | 172.35M |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | -4.56% | 5,005,165 | 74.68M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -1.10% | 43,972 | - |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | -0.72% | 435,571 | 868.45M |
| 116 | INBX | Inhibrx Biosciences, Inc. | 1.83B | 8.83% | 486,120 | 1.30M |
| 117 | NUVB | Nuvation Bio Inc. | 1.79B | 0.49% | 921,671 | 62.90M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.77B | 0.57% | 179,813 | - |
| 119 | ATAI | AtaiBeckley Inc. | 1.77B | 2.76% | 5,459,801 | 4.09M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 2.35% | 274,959 | 71.78M |
| 121 | INVA | Innoviva, Inc. | 1.74B | -0.30% | 113,493 | 411.33M |
| 122 | VCEL | Vericel Corporation | 1.73B | -1.11% | 186,971 | 276.26M |
| 123 | VIR | Vir Biotechnology, Inc. | 1.69B | -1.87% | 456,764 | 68.56M |
| 124 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | -2.19% | 282,542 | 123.67M |
| 125 | GENB | Generate Biomedicines, Inc. | 1.64B | -1.15% | 125,213 | 31.89M |
| 126 | OCS | Oculis Holding AG | 1.62B | -1.94% | 95,169 | 1.51M |
| 127 | MBX | MBX Biosciences, Inc. | 1.59B | -0.03% | 325,235 | - |
| 128 | BHVN | Biohaven Ltd. | 1.59B | -0.84% | 528,369 | - |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.56B | -0.19% | 52,643 | - |
| 130 | AGIO | Agios Pharmaceuticals, Inc. | 1.55B | -0.94% | 365,659 | 54.03M |
| 131 | NBTX | Nanobiotix S.A. | 1.54B | 6.85% | 77,493 | 38.27M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.52B | -1.97% | 128,267 | - |
| 133 | IMCR | Immunocore Holdings plc | 1.50B | -1.53% | 96,066 | 400.02M |
| 134 | IMTX | Immatics N.V. | 1.50B | -0.98% | 64,509 | 56.67M |
| 135 | ANAB | AnaptysBio, Inc. | 1.48B | -3.72% | 120,263 | 234.60M |
| 136 | VRDN | Viridian Therapeutics, Inc. | 1.47B | -0.63% | 356,222 | 70.85M |
| 137 | ARDX | Ardelyx, Inc. | 1.46B | -1.00% | 791,442 | 407.32M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.62% | 244,267 | 2.50M |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -1.98% | 5,498,273 | 263.50M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.41B | -0.41% | 975,808 | 42.73M |
| 141 | CRVS | Corvus Pharmaceuticals, Inc. | 1.40B | -6.83% | 869,676 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 0.60% | 105,785 | - |
| 143 | OLMA | Olema Pharmaceuticals, Inc. | 1.37B | -3.26% | 258,575 | - |
| 144 | PGEN | Precigen, Inc. | 1.37B | -2.53% | 1,317,678 | 9.68M |
| 145 | NVAX | Novavax, Inc. | 1.32B | -4.02% | 1,617,391 | 1.12B |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.29B | -8.81% | 183,781 | - |
| 147 | SVRA | Savara Inc. | 1.29B | -1.17% | 560,242 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.24B | 0.25% | 4,064,324 | 75.13M |
| 149 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.99% | 159,466 | - |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.23B | -0.46% | 181,492 | - |
| 151 | AKTS | Aktis Oncology, Inc. | 1.22B | 0.18% | 94,863 | 6.50M |
| 152 | PHAR | Pharming Group N.V. | 1.20B | -1.58% | 1,127 | 376.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.19B | -5.99% | 374,683 | 109.79M |
| 154 | GHRS | GH Research PLC | 1.17B | -0.37% | 163,924 | - |
| 155 | EYPT | EyePoint, Inc. | 1.17B | -1.54% | 329,521 | 31.37M |
| 156 | DBVT | DBV Technologies S.A. | 1.16B | -1.58% | 106,765 | 5.64M |
| 157 | SEPN | Septerna, Inc. | 1.15B | -0.77% | 116,671 | 45.95M |
| 158 | QURE | uniQure N.V. | 1.14B | 1.41% | 312,970 | 16.10M |
| 159 | ZBIO | Zenas BioPharma, Inc. | 1.13B | -5.01% | 146,576 | 10.00M |
| 160 | IVA | Inventiva S.A. | 1.11B | 0.57% | 110,345 | 7.94M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.07B | -0.84% | 443,959 | - |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -1.08% | 332,590 | 291.85M |
| 163 | ANNX | Annexon, Inc. | 1.03B | 0.96% | 979,846 | - |
| 164 | GERN | Geron Corporation | 983.78M | -0.97% | 3,853,924 | 183.88M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 976.04M | -2.06% | 650,040 | 76.20M |
| 166 | KALV | KalVista Pharmaceuticals, Inc. | 968.62M | -3.32% | 1,090,056 | 73.62M |
| 167 | OMER | Omeros Corporation | 964.03M | 0.15% | 267,705 | - |
| 168 | EVMN | Evommune, Inc. | 963.67M | -1.35% | 79,527 | 13.00M |
| 169 | SANA | Sana Biotechnology, Inc. | 960.31M | -5.15% | 1,124,594 | - |
| 170 | CMPX | Compass Therapeutics, Inc. | 947.26M | -1.13% | 257,298 | 850.00K |
| 171 | ANRO | Alto Neuroscience, Inc. | 943.79M | -0.87% | 92,469 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 933.46M | -0.29% | 197,400 | 10.00M |
| 173 | XNCR | Xencor, Inc. | 931.40M | -1.17% | 89,825 | 125.58M |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 925.36M | -0.68% | 576,383 | 175.11M |
| 175 | MGTX | MeiraGTx Holdings plc | 896.88M | -3.39% | 326,357 | 81.39M |
| 176 | FTRE | Fortrea Holdings Inc. | 896.67M | -8.67% | 586,297 | 2.72B |
| 177 | LBRX | LB Pharmaceuticals Inc | 885.34M | -2.85% | 52,726 | - |
| 178 | DRUG | Bright Minds Biosciences Inc. | 875.40M | 0.05% | 84,418 | - |
| 179 | MRVI | Maravai LifeSciences Holdings, Inc. | 868.89M | -8.40% | 938,385 | 185.74M |
| 180 | CBIO | Crescent Biopharma, Inc. | 868.54M | -3.08% | 207,178 | 10.84M |
| 181 | SLS | SELLAS Life Sciences Group, Inc. | 848.53M | -1.15% | 1,969,653 | - |
| 182 | TBPH | Theravance Biopharma, Inc. | 846.29M | -0.81% | 81,324 | 107.46M |
| 183 | ABUS | Arbutus Biopharma Corporation | 840.93M | -3.61% | 547,471 | 14.08M |
| 184 | MNKD | MannKind Corporation | 838.38M | -0.91% | 1,176,307 | 348.97M |
| 185 | KURA | Kura Oncology, Inc. | 834.81M | -1.31% | 318,138 | 67.48M |
| 186 | SGP | SpyGlass Pharma, Inc. | 824.63M | 0.73% | 72,578 | - |
| 187 | SLDB | Solid Biosciences Inc. | 823.56M | -0.36% | 240,407 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 817.16M | -0.90% | 42,866 | - |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 809.23M | -3.40% | 166,310 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 803.19M | -2.30% | 3,581,486 | 22.00K |
| 191 | VOR | Vor Biopharma Inc. | 798.70M | -3.79% | 316,900 | - |
| 192 | SPRY | ARS Pharmaceuticals, Inc. | 789.41M | -5.36% | 888,456 | 84.28M |
| 193 | RLMD | Relmada Therapeutics, Inc. | 765.68M | 3.40% | 250,452 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 730.85M | -5.22% | 927,985 | 49.80M |
| 195 | FBRX | Forte Biosciences, Inc. | 730.67M | 0.07% | 58,030 | - |
| 196 | DRTS | Alpha Tau Medical Ltd. | 720.36M | 1.30% | 224,497 | - |
| 197 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 715.09M | 0.73% | 200,254 | - |
| 198 | TENX | Tenax Therapeutics, Inc. | 692.64M | -1.08% | 78,403 | - |
| 199 | PRME | Prime Medicine, Inc. | 692.38M | -1.26% | 733,615 | 4.63M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 689.42M | -2.33% | 24,234 | 116.59M |
| 201 | ARVN | Arvinas, Inc. | 674.79M | -0.75% | 247,228 | 262.60M |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 643.55M | -1.85% | 202,476 | - |
| 203 | ACRS | Aclaris Therapeutics, Inc. | 629.65M | 3.19% | 1,128,407 | 7.83M |
| 204 | ANL | Adlai Nortye Ltd. | 624.80M | -3.16% | 169,801 | 5.00M |
| 205 | PROK | ProKidney Corp. | 617.51M | -2.15% | 283,277 | 893.00K |
| 206 | EIKN | Eikon Therapeutics, Inc. | 617.18M | -1.72% | 59,996 | - |
| 207 | STTK | Shattuck Labs, Inc. | 609.95M | 4.13% | 118,644 | 1.00M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 602.97M | -2.10% | 234,891 | 106.47M |
| 209 | PRTA | Prothena Corporation plc | 591.09M | 2.43% | 224,388 | 9.68M |
| 210 | CRMD | CorMedix Inc. | 587.82M | 0.07% | 170,502 | 311.71M |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 583.51M | -5.77% | 1,132,879 | - |
| 212 | ABSI | Absci Corporation | 582.25M | 3.40% | 1,547,237 | 2.80M |
| 213 | STRO | Sutro Biopharma, Inc. | 580.52M | -1.38% | 55,404 | 102.48M |
| 214 | ENGN | enGene Therapeutics Inc. | 577.45M | 0.94% | 213,972 | - |
| 215 | OCGN | Ocugen, Inc. | 575.48M | 1.19% | 2,750,130 | 4.41M |
| 216 | RIGL | Rigel Pharmaceuticals, Inc. | 566.02M | 0.56% | 70,272 | 294.28M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 554.98M | -4.00% | 27,541 | 36.00K |
| 218 | FULC | Fulcrum Therapeutics, Inc. | 542.79M | 5.16% | 341,777 | 80.00M |
| 219 | IMMX | Immix Biopharma, Inc. | 541.25M | 0.29% | 134,357 | - |
| 220 | ZURA | Zura Bio Limited | 540.82M | 0.18% | 151,260 | - |
| 221 | VSTM | Verastem, Inc. | 540.23M | 1.32% | 515,908 | 30.91M |
| 222 | CADL | Candel Therapeutics, Inc. | 534.70M | -0.54% | 914,674 | - |
| 223 | UPB | Upstream Bio, Inc. | 523.79M | -0.16% | 128,651 | 2.85M |
| 224 | TECX | Tectonic Therapeutic, Inc. | 521.90M | -2.47% | 54,909 | - |
| 225 | ARMP | Armata Pharmaceuticals, Inc. | 521.65M | 2.37% | 14,936 | 4.90M |
| 226 | ADCT | ADC Therapeutics SA | 515.12M | -0.98% | 196,627 | 81.36M |
| 227 | AGMB | AgomAb Therapeutics NV | 511.74M | -0.47% | 12,234 | - |
| 228 | MDXG | MiMedx Group, Inc. | 499.93M | 1.66% | 522,630 | 418.63M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 497.75M | -0.51% | 159,830 | 85.21M |
| 230 | VALN | Valneva SE | 485.03M | - | 208,573 | 205.07M |
| 231 | RGNX | REGENXBIO Inc. | 481.07M | -0.21% | 217,834 | 170.44M |
| 232 | AURA | Aura Biosciences, Inc. | 479.20M | -0.27% | 120,679 | - |
| 233 | CTNM | Contineum Therapeutics, Inc. | 470.06M | -2.85% | 35,105 | - |
| 234 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.57M | -4.62% | 393,201 | 170.16M |
| 235 | LRMR | Larimar Therapeutics, Inc. | 466.43M | -1.54% | 358,455 | - |
| 236 | VTVT | vTv Therapeutics Inc. | 462.88M | -7.79% | 38,023 | 17.00K |
| 237 | TRDA | Entrada Therapeutics, Inc. | 462.78M | -1.49% | 32,080 | 25.42M |
| 238 | XOMA | XOMA Royalty Corporation | 462.21M | -1.47% | 19,302 | 52.15M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 458.97M | -2.13% | 459,729 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 448.44M | -0.11% | 32,753 | 72.30M |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 448.35M | 0.31% | 54,885 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 438.46M | -1.23% | 51,090 | - |
| 243 | IVVD | Invivyd, Inc. | 438.35M | -3.13% | 505,781 | 53.43M |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 435.80M | 3.40% | 47,514 | - |
| 245 | CLYM | Climb Bio, Inc. | 430.87M | -3.01% | 152,914 | - |
| 246 | NGNE | Neurogene Inc. | 424.91M | -0.22% | 30,606 | 925.00K |
| 247 | PRTC | PureTech Health plc | 424.18M | -1.96% | 1,379 | 6.39M |
| 248 | XFOR | X4 Pharmaceuticals, Inc. | 421.87M | 4.98% | 291,590 | 35.11M |
| 249 | AUTL | Autolus Therapeutics plc | 419.18M | -1.56% | 575,832 | 75.39M |
| 250 | NMRA | Neumora Therapeutics, Inc. | 415.62M | -1.52% | 452,882 | - |
| 251 | PRLD | Prelude Therapeutics Incorporated | 414.28M | -4.41% | 246,772 | 12.14M |
| 252 | IPSC | Century Therapeutics, Inc. | 414.13M | -5.93% | 321,750 | 109.16M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 412.48M | -0.53% | 721,235 | - |
| 254 | LCTX | Lineage Cell Therapeutics, Inc. | 401.03M | -1.23% | 508,649 | 14.56M |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 396.98M | -0.80% | 23,865 | 66.98M |
| 256 | IMRX | Immuneering Corporation | 395.68M | 3.90% | 394,182 | - |
| 257 | AVTX | Avalo Therapeutics, Inc. | 391.63M | 1.10% | 264,215 | 59.00K |
| 258 | VNDA | Vanda Pharmaceuticals Inc. | 390.11M | -3.37% | 558,413 | 216.11M |
| 259 | NAGE | Niagen Bioscience, Inc. | 384.79M | -4.48% | 322,865 | 129.42M |
| 260 | PBYI | Puma Biotechnology, Inc. | 383.61M | 1.48% | 79,433 | 228.37M |
| 261 | PALI | Palisade Bio, Inc. | 380.89M | -2.78% | 5,108,640 | - |
| 262 | YDES | YD Bio Limited | 376.90M | 0.75% | 4,551 | 510.36K |
| 263 | IRD | Opus Genetics, Inc. | 373.53M | -4.02% | 243,316 | 14.20M |
| 264 | ALT | Altimmune, Inc. | 372.10M | -17.58% | 19,907,957 | 41.00K |
| 265 | SLN | Silence Therapeutics plc | 371.26M | -1.38% | 408,738 | 559.00K |
| 266 | SRZN | Surrozen, Inc. | 367.80M | -3.06% | 44,009 | 3.48M |
| 267 | OVID | Ovid Therapeutics Inc. | 356.06M | 1.50% | 885,495 | 7.25M |
| 268 | MNPR | Monopar Therapeutics Inc. | 353.14M | -0.99% | 86,376 | - |
| 269 | CABA | Cabaletta Bio, Inc. | 346.21M | -1.89% | 525,598 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 340.17M | -2.20% | 122,255 | 72.59M |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 339.19M | -6.62% | 188,372 | - |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 338.92M | -2.78% | 53,520 | - |
| 273 | GLSI | Greenwich LifeSciences, Inc. | 338.47M | -2.04% | 35,792 | - |
| 274 | RZLT | Rezolute, Inc. | 331.87M | -4.05% | 338,868 | - |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 330.62M | 6.59% | 623,331 | 1.00 |
| 276 | NGEN | NervGen Pharma Corp. | 322.91M | -0.87% | 14,865 | - |
| 277 | EDIT | Editas Medicine, Inc. | 321.02M | -1.50% | 420,067 | 40.52M |
| 278 | AVXL | Anavex Life Sciences Corp. | 316.02M | -5.54% | 339,815 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 314.56M | -1.78% | 283,090 | 5.82M |
| 280 | NERV | Minerva Neurosciences, Inc. | 309.09M | -4.08% | 31,803 | - |
| 281 | FHTX | Foghorn Therapeutics Inc. | 306.42M | -3.15% | 34,225 | 30.91M |
| 282 | ACIU | AC Immune SA | 303.56M | - | 199,614 | 4.51M |
| 283 | HELP | Cybin Inc. | 303.22M | 5.03% | 1,136,011 | - |
| 284 | CCCC | C4 Therapeutics, Inc. | 296.15M | -1.14% | 847,429 | 35.95M |
| 285 | LENZ | LENZ Therapeutics, Inc. | 295.99M | -5.51% | 296,407 | 19.09M |
| 286 | ARTV | Artiva Biotherapeutics, Inc. | 291.16M | 0.43% | 59,521 | 251.00K |
| 287 | TARA | Protara Therapeutics, Inc. | 290.16M | -0.83% | 145,983 | - |
| 288 | NBP | NovaBridge Biosciences | 287.96M | -3.49% | 112,851 | - |
| 289 | CLLS | Cellectis S.A. | 283.29M | -0.75% | 3,696 | 79.59M |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 282.66M | 3.78% | 830,050 | 26.87M |
| 291 | CGEN | Compugen Ltd. | 278.46M | 4.06% | 280,995 | 72.76M |
| 292 | SABS | SAB Biotherapeutics, Inc. | 277.59M | -1.00% | 276,148 | 114.70K |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 275.76M | -9.02% | 1,422,371 | - |
| 294 | ALEC | Alector, Inc. | 271.49M | 0.41% | 106,064 | 21.05M |
| 295 | CHRS | Coherus Oncology, Inc. | 265.25M | -4.44% | 413,295 | 42.17M |
| 296 | PLYX | Polaryx Therapeutics, Inc. | 248.55M | -4.72% | 47,010 | - |
| 297 | ADAG | Adagene Inc. | 248.43M | -0.53% | 40,815 | 7.67M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 245.79M | -0.24% | 44,569 | 33.48M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 245.01M | - | 107,090 | 82.03M |
| 300 | VYGR | Voyager Therapeutics, Inc. | 243.76M | -1.21% | 93,921 | 40.37M |
| 301 | MIST | Milestone Pharmaceuticals Inc. | 237.94M | -3.48% | 784,112 | 1.55M |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 234.55M | -2.35% | 15,642 | 19.39M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 233.90M | -1.21% | 12,533 | 3.50M |
| 304 | NVCT | Nuvectis Pharma, Inc. | 230.74M | -1.25% | 6,526 | - |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 229.95M | -0.15% | 15,310 | 44.64M |
| 306 | KROS | Keros Therapeutics, Inc. | 227.34M | 0.79% | 63,494 | 244.06M |
| 307 | REPL | Replimune Group, Inc. | 224.60M | 19.82% | 10,502,858 | - |
| 308 | CRBU | Caribou Biosciences, Inc. | 224.20M | -1.69% | 841,702 | 11.16M |
| 309 | ELTX | Elicio Therapeutics, Inc. | 220.94M | 0.25% | 37,639 | - |
| 310 | OABI | OmniAb, Inc. | 220.07M | 1.33% | 215,539 | 18.67M |
| 311 | CDXS | Codexis, Inc. | 219.69M | -2.12% | 347,186 | 70.39M |
| 312 | CNTX | Context Therapeutics Inc. | 219.59M | -0.83% | 595,775 | - |
| 313 | ACHV | Achieve Life Sciences, Inc. | 218.28M | -3.07% | 306,858 | - |
| 314 | ENLV | Enlivex Ltd. | 215.02M | 1.94% | 344,026 | - |
| 315 | ALXO | ALX Oncology Holdings Inc. | 213.21M | -4.71% | 548,196 | - |
| 316 | MDWD | MediWound Ltd. | 211.93M | -3.45% | 20,607 | 16.96M |
| 317 | MGNX | MacroGenics, Inc. | 210.38M | -3.22% | 213,290 | 149.50M |
| 318 | NKTX | Nkarta, Inc. | 208.88M | -5.18% | 417,447 | - |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 204.69M | -4.92% | 244,313 | 146.07M |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 202.92M | - | 103,960 | - |
| 321 | KRRO | Korro Bio, Inc. | 199.90M | -0.93% | 15,494 | 6.39M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 198.86M | -1.13% | 80,419 | - |
| 323 | SGMT | Sagimet Biosciences Inc. | 196.16M | -4.14% | 91,370 | - |
| 324 | WHWK | Whitehawk Therapeutics, Inc. | 195.87M | -1.89% | 50,189 | 7.15M |
| 325 | DTIL | Precision BioSciences, Inc. | 194.17M | -4.87% | 94,818 | 34.26M |
| 326 | UNCY | Unicycive Therapeutics, Inc. | 189.79M | -2.46% | 225,924 | - |
| 327 | HRTX | Heron Therapeutics, Inc. | 185.11M | -3.75% | 916,296 | 154.90M |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 182.54M | -1.98% | 132,611 | 13.11M |
| 329 | RNAC | Cartesian Therapeutics, Inc. | 181.59M | -0.58% | 31,675 | 2.80M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 179.85M | -3.24% | 57,936 | - |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 178.74M | -6.87% | 560,912 | 70.00M |
| 332 | PRQR | ProQR Therapeutics N.V. | 175.43M | -4.86% | 226,800 | 19.19M |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 173.63M | -2.05% | 337,388 | 52.74M |
| 334 | MENS | Jyong Biotech Ltd. | 171.49M | -2.19% | 20,565 | - |
| 335 | SPRO | Spero Therapeutics, Inc. | 168.17M | 1.57% | 95,268 | 66.80M |
| 336 | MOLN | Molecular Partners AG | 163.95M | 2.53% | 1,597 | 856.30K |
| 337 | GALT | Galectin Therapeutics Inc. | 162.26M | 0.61% | 69,153 | - |
| 338 | ANTX | AN2 Therapeutics, Inc. | 156.53M | 8.75% | 114,223 | - |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 156.51M | -0.78% | 18,725 | 2.00M |
| 340 | ALPS | Alps Group Inc | 156.42M | - | 11,420 | 3.74M |
| 341 | TLSA | Tiziana Life Sciences Ltd | 156.34M | -1.21% | 99,456 | - |
| 342 | FATE | Fate Therapeutics, Inc. | 155.79M | -2.19% | 393,479 | 6.65M |
| 343 | HUMA | Humacyte, Inc. | 155.75M | -0.48% | 1,911,820 | 2.04M |
| 344 | KALA | KALA BIO, Inc. | 152.53M | -7.03% | 1,519,832 | - |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 152.07M | -4.80% | 1,087,261 | - |
| 346 | SPRB | Spruce Biosciences, Inc. | 148.63M | 5.04% | 54,860 | 697.00K |
| 347 | HURA | TuHURA Biosciences, Inc. | 148.14M | -13.06% | 1,208,640 | - |
| 348 | ACOG | Alpha Cognition Inc. | 148.06M | -2.72% | 42,426 | 10.22M |
| 349 | AGEN | Agenus Inc. | 147.83M | -2.28% | 388,928 | 114.20M |
| 350 | CNTB | Connect Biopharma Holdings Limited | 144.13M | -1.92% | 82,462 | 64.00K |
| 351 | EQ | Equillium, Inc. | 143.52M | -2.58% | 207,071 | 4.39M |
| 352 | KLRS | Kalaris Therapeutics, Inc. | 139.98M | -3.55% | 11,551 | - |
| 353 | BMEA | Biomea Fusion, Inc. | 134.64M | 0.66% | 649,889 | - |
| 354 | KZIA | Kazia Therapeutics Limited | 131.98M | 0.17% | 68,011 | 1.27M |
| 355 | IPHA | Innate Pharma S.A. | 129.31M | 1.40% | 2,234 | 10.57M |
| 356 | ONCY | Oncolytics Biotech Inc. | 127.74M | -4.35% | 336,577 | - |
| 357 | IMUX | Immunic, Inc. | 119.70M | 1.94% | 4,389,341 | - |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 118.95M | -3.54% | 22,769 | 39.99K |
| 359 | CRDF | Cardiff Oncology, Inc. | 115.54M | -2.31% | 150,944 | 593.00K |
| 360 | AARD | Aardvark Therapeutics, Inc. | 115.08M | -4.61% | 24,775 | - |
| 361 | IFRX | InflaRx N.V. | 113.50M | -1.88% | 354,615 | 34.44K |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 113.04M | 1.15% | 29,323 | 35.58M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 112.59M | -2.33% | 814,381 | - |
| 364 | GNLX | Genelux Corporation | 111.37M | -1.18% | 39,785 | 8.00K |
| 365 | CBUS | Cibus, Inc. | 111.21M | -2.01% | 140,610 | 3.64M |
| 366 | SEER | Seer, Inc. | 110.87M | -0.76% | 145,450 | 16.58M |
| 367 | PYXS | Pyxis Oncology, Inc. | 110.27M | -6.65% | 140,334 | 13.86M |
| 368 | VANI | Vivani Medical, Inc. | 109.62M | -2.63% | 86,587 | - |
| 369 | PEPG | PepGen Inc. | 109.55M | -4.52% | 349,559 | - |
| 370 | SGMO | Sangamo Therapeutics, Inc. | 104.31M | -2.37% | 3,629,587 | 39.55M |
| 371 | ANIX | Anixa Biosciences, Inc. | 102.43M | -2.71% | 68,147 | - |
| 372 | TTRX | Turn Therapeutics Inc. | 99.94M | -1.61% | 1,745 | - |
| 373 | COEP | Coeptis Therapeutics Holdings, Inc. | 99.70M | 6.09% | 70,420 | 1.36M |
| 374 | COYA | Coya Therapeutics, Inc. | 99.22M | -4.08% | 75,984 | 7.95M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 99.09M | -0.54% | 9,990 | - |
| 376 | ALDX | Aldeyra Therapeutics, Inc. | 96.89M | -5.29% | 545,471 | - |
| 377 | QTTB | Q32 Bio Inc. | 96.12M | -1.20% | 98,043 | 53.74M |
| 378 | GUTS | Fractyl Health, Inc. | 93.87M | 0.20% | 736,213 | 3.00K |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 93.41M | - | 338,036 | 65.34K |
| 380 | NRXP | NRx Pharmaceuticals, Inc. | 93.27M | -4.94% | 499,537 | 1.23M |
| 381 | PYPD | PolyPid Ltd. | 91.22M | 1.49% | 34,866 | - |
| 382 | EXOZ | eXoZymes, Inc. | 90.34M | 1.48% | 201 | -700.00 |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 90.33M | -4.74% | 276,073 | 1.63M |
| 384 | GOSS | Gossamer Bio, Inc. | 87.38M | -4.51% | 1,953,894 | 48.47M |
| 385 | ACET | Adicet Bio, Inc. | 86.53M | -3.13% | 38,111 | - |
| 386 | OKYO | OKYO Pharma Limited | 85.54M | 0.62% | 162,461 | - |
| 387 | CSBR | Champions Oncology, Inc. | 84.15M | 0.83% | 1,034 | 57.95M |
| 388 | NRXS | NeurAxis, Inc. | 83.57M | -0.53% | 80,189 | 3.57M |
| 389 | GANX | Gain Therapeutics, Inc. | 82.37M | -4.41% | 201,938 | - |
| 390 | LONA | LeonaBio, Inc. | 82.19M | -4.48% | 48,790 | - |
| 391 | FLNA | Filana Therapeutics, Inc. | 81.16M | -0.59% | 175,575 | - |
| 392 | PLRX | Pliant Therapeutics, Inc. | 80.18M | 0.39% | 178,499 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 80.09M | -2.94% | 224,385 | - |
| 394 | ATYR | aTyr Pharma, Inc. | 79.92M | -3.46% | 292,510 | 190.00K |
| 395 | XBIT | XBiotech Inc. | 78.81M | 2.17% | 17,042 | - |
| 396 | IMMP | Immutep Limited | 78.10M | -3.71% | 1,323,056 | 5.28M |
| 397 | MCRB | Seres Therapeutics, Inc. | 77.74M | -3.91% | 22,081 | 789.00K |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 76.79M | -2.70% | 348,993 | - |
| 399 | PTHS | Pelthos Therapeutics Inc. | 76.20M | -1.26% | 4,968 | 16.80M |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 74.78M | -2.03% | 216,747 | - |
| 401 | ESLA | Estrella Immunopharma, Inc. | 74.66M | -2.78% | 52,246 | - |
| 402 | TCRX | TScan Therapeutics, Inc. | 72.85M | -3.02% | 446,130 | 10.33M |
| 403 | FBIO | Fortress Biotech, Inc. | 72.13M | -0.44% | 186,439 | 63.26M |
| 404 | ICCC | ImmuCell Corporation | 72.01M | 1.79% | 2,182 | 27.64M |
| 405 | ATHE | Alterity Therapeutics Limited | 70.09M | -4.19% | 10,429 | 4.43M |
| 406 | IBO | Impact BioMedical Inc. | 69.01M | -3.09% | 24,775 | 32.00K |
| 407 | BYSI | BeyondSpring Inc. | 68.88M | 2.76% | 4,867 | 1.88M |
| 408 | OKUR | OnKure Therapeutics, Inc. | 67.75M | -1.10% | 63,565 | - |
| 409 | MNOV | MediciNova, Inc. | 67.43M | -2.84% | 18,237 | 409.66K |
| 410 | PDSB | PDS Biotechnology Corporation | 67.26M | -6.59% | 210,685 | - |
| 411 | GRCE | Grace Therapeutics, Inc. | 66.93M | 0.35% | 654,252 | - |
| 412 | IMA | ImageneBio, Inc. | 66.33M | -1.33% | 24,511 | 800.00K |
| 413 | IBIO | iBio, Inc. | 65.96M | -4.95% | 453,187 | 300.00K |
| 414 | CING | Cingulate Inc. | 63.14M | -3.21% | 256,651 | - |
| 415 | ANVS | Annovis Bio, Inc. | 61.64M | -2.99% | 442,009 | - |
| 416 | OSTX | OS Therapies Incorporated | 60.75M | 1.05% | 252,091 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 60.34M | -6.54% | 47,665 | 20.70M |
| 418 | EDSA | Edesa Biotech, Inc. | 59.53M | -4.69% | 124,294 | - |
| 419 | ACTU | Actuate Therapeutics, Inc. | 58.69M | -10.97% | 147,501 | - |
| 420 | ENTX | Entera Bio Ltd. | 56.41M | -0.82% | 31,060 | 42.00K |
| 421 | INKT | MiNK Therapeutics, Inc. | 56.21M | -0.18% | 5,862 | - |
| 422 | CUE | Cue Biopharma, Inc. | 55.76M | -1.57% | 1,295,951 | 27.47M |
| 423 | TIL | Instil Bio, Inc. | 54.76M | -3.98% | 6,652 | - |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 54.56M | -2.01% | 38,494 | 25.21M |
| 425 | KZR | Kezar Life Sciences, Inc. | 53.71M | -0.34% | 9,921 | - |
| 426 | RNTX | Rein Therapeutics Inc. | 51.87M | -1.60% | 35,679 | - |
| 427 | MREO | Mereo BioPharma Group plc | 50.92M | -0.75% | 356,496 | 500.00K |
| 428 | RADX | Radiopharm Theranostics Limited | 50.76M | -1.94% | 17,966 | 10.86M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 49.99M | -2.44% | 18,713 | - |
| 430 | NTRB | Nutriband Inc. | 49.72M | -1.92% | 2,608 | 2.28M |
| 431 | XLO | Xilio Therapeutics, Inc. | 49.50M | -0.47% | 19,930 | 43.77M |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 49.10M | -3.92% | 331,423 | - |
| 433 | PSTV | Plus Therapeutics, Inc. | 48.38M | -7.48% | 149,348 | 5.21M |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 47.50M | 0.85% | 17,210 | - |
| 435 | NXTC | NextCure, Inc. | 45.57M | 6.67% | 41,707 | - |
| 436 | RLYB | Rallybio Corporation | 45.44M | 0.47% | 8,898 | 858.00K |
| 437 | HYPD | Hyperion DeFi, Inc. | 45.34M | - | 70,631 | 813.46K |
| 438 | LIXT | Lixte Biotechnology Holdings, Inc. | 45.31M | 1.83% | 94,417 | - |
| 439 | LITS | Lite Strategy, Inc. | 44.00M | 1.68% | 147,675 | - |
| 440 | HOWL | Werewolf Therapeutics, Inc. | 43.74M | -3.49% | 28,191 | 1.14M |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 42.59M | 0.44% | 10,157 | - |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 41.46M | -5.00% | 107,694 | 90.00K |
| 443 | ATRA | Atara Biotherapeutics, Inc. | 41.30M | -2.51% | 5,300 | 120.77M |
| 444 | RNXT | RenovoRx, Inc. | 41.23M | -3.50% | 249,282 | 1.12M |
| 445 | PTN | Palatin Technologies, Inc. | 40.41M | -3.05% | 4,466 | 8.96M |
| 446 | ALGS | Aligos Therapeutics, Inc. | 38.33M | -4.84% | 99,899 | 2.19M |
| 447 | VERU | Veru Inc. | 38.17M | -2.54% | 25,231 | 16.89M |
| 448 | INMB | INmune Bio Inc. | 37.22M | -2.10% | 54,562 | 50.00K |
| 449 | CRVO | CervoMed Inc. | 36.48M | - | 25,693 | 4.01M |
| 450 | EVAX | Evaxion A/S | 35.28M | -0.94% | 25,546 | 7.53M |
| 451 | PLUR | Pluri Inc. | 34.27M | 1.79% | 4,768 | 1.34M |
| 452 | CELU | Celularity Inc. | 34.17M | 1.28% | 9,064 | 40.58M |
| 453 | BOLD | Boundless Bio, Inc. | 34.06M | -1.94% | 24,772 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 32.90M | -2.95% | 5,466 | - |
| 455 | SNTI | Senti Biosciences, Inc. | 32.39M | -8.77% | 148,378 | 22.00K |
| 456 | IGC | IGC Pharma, Inc. | 31.95M | -5.01% | 1,104,783 | 1.11M |
| 457 | DARE | Daré Bioscience, Inc. | 31.30M | -5.29% | 256,051 | 1.03M |
| 458 | DYAI | Dyadic International, Inc. | 30.97M | 2.41% | 3,359 | 3.09M |
| 459 | SKYE | Skye Bioscience, Inc. | 29.86M | -5.56% | 114,714 | - |
| 460 | OTLK | Outlook Therapeutics, Inc. | 29.48M | -2.89% | 2,762,511 | 205.70K |
| 461 | LSTA | Lisata Therapeutics, Inc. | 29.43M | -4.72% | 76,527 | 170.00K |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 28.99M | -4.33% | 13,355 | - |
| 463 | APLM | Apollomics, Inc. | 28.69M | -0.96% | 635 | 6.93M |
| 464 | BCTX | BriaCell Therapeutics Corp. | 28.61M | -1.92% | 127,045 | - |
| 465 | KYNB | Kyntra Bio, Inc. | 28.41M | -2.36% | 1,550 | 6.44M |
| 466 | LGVN | Longeveron Inc. | 28.11M | -6.80% | 303,738 | 1.20M |
| 467 | ABVC | ABVC BioPharma, Inc. | 27.92M | -4.24% | 27,373 | 797.92K |
| 468 | NNVC | NanoViricides, Inc. | 27.75M | -4.10% | 72,642 | - |
| 469 | PLRZ | Polyrizon Ltd. | 27.08M | 3.76% | 43,080 | - |
| 470 | AEON | AEON Biopharma, Inc. | 26.82M | -2.75% | 62,002 | - |
| 471 | CVM | CEL-SCI Corporation | 26.79M | -0.90% | 18,690 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 26.58M | - | 8,563 | 14.99M |
| 473 | LTRN | Lantern Pharma Inc. | 26.57M | -11.57% | 109,718 | - |
| 474 | TPST | Tempest Therapeutics, Inc. | 26.25M | -1.08% | 83,931 | - |
| 475 | BRNS | Barinthus Biotherapeutics plc | 26.06M | 2.05% | 8,360 | 14.97M |
| 476 | JSPR | Jasper Therapeutics, Inc. | 25.86M | -5.68% | 129,118 | - |
| 477 | NRSN | NeuroSense Therapeutics Ltd. | 25.10M | 1.10% | 55,496 | - |
| 478 | MRKR | Marker Therapeutics, Inc. | 24.84M | -3.25% | 78,314 | 3.55M |
| 479 | CRIS | Curis, Inc. | 24.26M | -1.23% | 101,047 | 9.44M |
| 480 | SER | Serina Therapeutics, Inc. | 23.52M | -2.05% | 95,346 | 130.00K |
| 481 | VTGN | Vistagen Therapeutics, Inc. | 23.08M | -3.29% | 336,608 | 789.00K |
| 482 | LEXX | Lexaria Bioscience Corp. | 22.87M | -4.88% | 60,780 | 368.00K |
| 483 | QNCX | Quince Therapeutics, Inc. | 22.72M | 1.72% | 1,385,425 | - |
| 484 | XCUR | Exicure, Inc. | 22.63M | -2.42% | 71,477 | 500.00K |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 22.60M | 17.46% | 2,597,507 | 3.94M |
| 486 | VYNE | VYNE Therapeutics Inc. | 21.62M | 0.23% | 11,783 | 570.00K |
| 487 | ALLR | Allarity Therapeutics, Inc. | 21.59M | -2.50% | 89,636 | 320.00K |
| 488 | NCEL | NewcelX Ltd. | 20.51M | 22.95% | 152,804 | - |
| 489 | OSRH | OSR Holdings, Inc. | 20.17M | 3.96% | 420,207 | 2.91M |
| 490 | PBM | Psyence Biomedical Ltd. | 20.11M | -2.23% | 890,691 | - |
| 491 | PASG | Passage Bio, Inc. | 19.55M | -0.57% | 56,229 | - |
| 492 | COCP | Cocrystal Pharma, Inc. | 19.44M | -4.08% | 149,689 | - |
| 493 | QNTM | Quantum BioPharma Ltd. | 19.42M | -3.73% | 72,524 | - |
| 494 | TOVX | Theriva Biologics, Inc. | 17.95M | 4.85% | 7,879,701 | - |
| 495 | KTTA | Pasithea Therapeutics Corp. | 17.89M | 1.06% | 112,923 | - |
| 496 | ICU | SeaStar Medical Holding Corporation | 17.23M | -3.25% | 21,432 | 1.23M |
| 497 | LPCN | Lipocine Inc. | 17.07M | -3.35% | 53,593 | 1.98M |
| 498 | GNTA | Genenta Science S.p.A. | 16.49M | -2.10% | 32,146 | - |
| 499 | HIND | Vyome Holdings, Inc. | 16.21M | 1.76% | 8,807 | 319.71K |
| 500 | CDT | CDT Equity Inc. | 15.16M | -0.32% | 24,177 | - |